Ann: Annual General Meeting - Notice of Meeting, page-94

Couple of Questions to Ask. .What’s happened at this end of IP Deals.
The unconditional IP agreement means BrainChip will deliver its Akida 1.0 neural network IP via a single-use, royalty-bearing, worldwide IP design license, thereby allowing Renesas to use Akida in its system-on-chip products.

BrainChip has been tasked with providing implementation support services — at an agreed fee to cover costs — aimed at facilitating Renesas’ adoption and commercialisation of the Akida-licensed product during the first year of the license agreement.

Moreover, the agreement includes provisions for the payment of ongoing royalties based on the volume of units sold, commencing at a “certain agreed volume threshold and the net sale price of the customer’s [Renesas’s] products”. November 21 The four-year agreementprovides MegaChipswith anintellectual property license for use in designing and manufacturingBrainChip’s Akida technologyinto external customer’s system on chip designs.In exchange fortheIPandcertain engineeringservices, BrainChip will receivean upfront license fee and additionalpayments over the term of the agreement. BrainChipis also eligible to receiveadditional compensation based onengineering efforts, softwaresupportfees and royaltiesassociated with MegaChip’s customer engagements.This agreementprovidesBrainChip access to a significant portfolio of world class customers andopensupnewglobalopportunities for the Akida technology. The Answer probably by Sean it’s not upto BRN to know where or what product the IP has been manufactured or integrated into